Company / Current Assets per Share
GYRE THERAPEUTICS, INC. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.19
FY2025
5-year range
$0.66 / $2.33
FY2021-FY2025
Trend
+40.2%
vs FY2024
Sector context
#190 of 210
Health Care
What the data says
Among 210 Health Care companies, GYRE THERAPEUTICS, INC. is in the bottom 10% for current assets per share. Current Assets per Share has fluctuated over the past 10 years, ranging from $0.66 in FY2022 to $48.16 in FY2016.
Based on SEC 10-K filings.
1.19 in FY2025 with a 5-year CAGR of -30.7%.
Improved from $0.90 to $1.19 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +21.8%
- 5-Year CAGR
- -30.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 210This company $1.19 Sector average $134.38
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 40.2% year-over-year.
- Ranks #190 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2016.
- Lowest current assets per share in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.19 | +40.2% |
| FY2024 | $0.85 | -6.0% |
| FY2023 | $0.90 | +37.2% |
| FY2022 | $0.66 | -71.8% |
| FY2021 | $2.33 | -68.7% |
| FY2020 | $7.43 | -7.5% |
| FY2019 | $8.04 | -60.6% |
| FY2018 | $20.39 | +78.5% |
| FY2017 | $11.42 | -76.3% |
| FY2016 | $48.16 | -79.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026